Fresh Recalls

FDAClass III · Drug · Recall D-0608-2026 · Recalled June 24, 2026

Focalin XR (dexmethylphenidate HCl) 5 mg recall — Sandoz Inc

Agency report date: June 24, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Focalin XR (dexmethylphenidate HCl) 5 mg
Company / brand
Sandoz
Lot / serial / date codes
Lot VA0099422; Exp. Date June 30, 2028
Distribution
U.S. Nationwide
Agency product description and boundaries

Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured by Societal CDMO Gainesville, LLC, Gainesville, GA 30504. NDC: 66758-235-31

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Labeling: Incorrect or Missing Lot and/or Exp Date

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: Focalin XR (dexmethylphenidate HCl) 5 mg

3. Open the official notice or contact

Official recall ID
D-0608-2026
Brand
Sandoz
Classification
Class III
Units affected
7,803 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Princeton, NJ, United States
Firm address
100 College Rd W, 08540-6604

Identifying details (verbatim from the notice)

Product codes / lots
Lot VA0099422; Exp. Date June 30, 2028
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
99121
Recall initiated
June 1, 2026
FDA classified
June 22, 2026
FDA report date
June 24, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page